CD8A and neoplasm: Using the murine Microenvironment Cell Population counter (mMCP‐counter),[33] an immune deconvolution algorithm designed for bulk RNA‐seq data, we observed a significant increase in CD3+ and CD8+ T cells in the combination treatment group, indicative of enhanced anti‐tumor immunity (Figure 4P; Figure S5O, Supporting Information).